Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Berlan

Showing results (61-70 of 141) with videos related to

Pageof 15
Sort By:
Clinical Neuropharmacology|February 1, 1994
Lacrimation in Parkinson's diseaseH Bagheri, M Berlan, J M Senard, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 27, 1999
Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cellsC Carpéné, J Galitzky, E Fontana, et al.
The American Journal of Physiology|March 1, 1993
Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholaminesJ Galitzky, M Reverte, M Portillo, et al.
European Journal of Clinical Investigation|December 1, 1988
Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteersJ Galitzky, M Taouis, M Berlan, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dogM Berlan, J Galitzky, A Bousquet-Melou, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanismsG Tavernier, J Galitzky, A Bousquet-Melou, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1989
Obesity modifies the adrenergic status of dog adipose tissueM Taosis, P Valet, L Estan, et al.
European Journal of Pharmacology|April 28, 1995
Desensitization of beta-adrenergic responses in adipocytes involves receptor subtypes and cAMP phosphodiesteraseA Bousquet-Mélou, J Galitzky, C M Moreno, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteersJ Galitzky, D Rivière, M A Tran, et al.
British Journal of Pharmacology|October 1, 1990
Reserpine induces vascular alpha 2-adrenergic supersensitivity and platelet alpha 2-adrenoceptor up-regulation in dogL Estan, J M Senard, M A Tran, et al.
Pageof 15

Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
Clinical Neuropharmacology|February 1, 1994
Lacrimation in Parkinson's diseaseH Bagheri, M Berlan, J M Senard, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 27, 1999
Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cellsC Carpéné, J Galitzky, E Fontana, et al.
The American Journal of Physiology|March 1, 1993
Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholaminesJ Galitzky, M Reverte, M Portillo, et al.
European Journal of Clinical Investigation|December 1, 1988
Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteersJ Galitzky, M Taouis, M Berlan, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dogM Berlan, J Galitzky, A Bousquet-Melou, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanismsG Tavernier, J Galitzky, A Bousquet-Melou, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1989
Obesity modifies the adrenergic status of dog adipose tissueM Taosis, P Valet, L Estan, et al.
European Journal of Pharmacology|April 28, 1995
Desensitization of beta-adrenergic responses in adipocytes involves receptor subtypes and cAMP phosphodiesteraseA Bousquet-Mélou, J Galitzky, C M Moreno, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteersJ Galitzky, D Rivière, M A Tran, et al.
British Journal of Pharmacology|October 1, 1990
Reserpine induces vascular alpha 2-adrenergic supersensitivity and platelet alpha 2-adrenoceptor up-regulation in dogL Estan, J M Senard, M A Tran, et al.
Pageof 15